Stryker Corporation
275.39USD
-1.0400 (-0.38%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $3.59▼ | $3.68 | 1 | 21 |
| Next quarter | $5.15▼ | $5.19 | 8 | 11 |
| Current year | $15.02▲ | $14.99 | 20 | 3 |
| Next year | $16.75▲ | $16.72 | 17 | 6 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $3.49 | $3.69 | +0.20 (+5.8%) |
| 2026-03-31 | $2.98 | $2.6 | -0.38 (-12.9%) |
| 2025-12-31 | $4.4 | $4.47 | +0.07 (+1.7%) |
| 2025-09-30 | $3.13 | $3.19 | +0.06 (+1.9%) |
386 ratings from 48 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Wolfe Research | Downgraded from Outperform | Peer Perform | — | Aug 13, 2026 |
| Citizens | Maintained | Market Outperform | $440 $400 | Aug 3, 2026 |
| RBC Capital | Maintained | Outperform | $435 $420 | Jul 31, 2026 |
| JP Morgan | Maintained | Overweight | $400 $350 | Jul 31, 2026 |
| Piper Sandler | Maintained | Overweight | $420 $390 | Jul 31, 2026 |
| Truist Securities | Maintained | Hold | $330 $340 | Jul 31, 2026 |
| BTIG | Maintained | Buy | $371 $358 | Jul 31, 2026 |
| BMO Capital | Initiated from Market Perform | Outperform | $369 | Jul 9, 2026 |
| Evercore ISI Group | Maintained | Outperform | $355 $350 | Jul 6, 2026 |
| Leerink Partners | Maintained | Outperform | $410 $407 | Jun 5, 2026 |
| Truist Securities | Reiterated | Hold | $380 $330 | May 4, 2026 |
| Barclays | Maintained | Overweight | $469 $394 | May 4, 2026 |
| Canaccord Genuity | Maintained | Buy | $435 $400 | May 1, 2026 |
| JP Morgan | Maintained | Overweight | $445 $400 | May 1, 2026 |
| Evercore ISI Group | Maintained | Outperform | $365 $355 | May 1, 2026 |
| Wells Fargo | Maintained | Overweight | $456 $418 | May 1, 2026 |
| Needham | Maintained | Buy | $454 $418 | May 1, 2026 |
| BTIG | Maintained | Buy | $397 $379 | May 1, 2026 |
| Truist Securities | Maintained | Hold | $395 $380 | Apr 15, 2026 |
| BTIG | Reiterated | Buy | $397 | Apr 14, 2026 |
| Leerink Partners | Initiated | Outperform | $410 | Apr 13, 2026 |
| Goldman Sachs | Maintained | Neutral | $403 $357 | Apr 9, 2026 |
| Citigroup | Maintained | Buy | $420 $385 | Apr 7, 2026 |
| Evercore ISI Group | Maintained | Outperform | $400 $365 | Apr 6, 2026 |
| UBS | Maintained | Neutral | $400 $380 | Mar 17, 2026 |
5 filings from 1 insider · 26 buy / 6 sell over 6m
Officers and directors of SYK, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| BRAINERD MARY KDirector | Buyindirect | 18 | $225.19 | $4k | Nov 22, 2022 |
| BRAINERD MARY KDirector | Buyindirect | 3 | $185.65 | $557 | Jun 12, 2020 |
| BRAINERD MARY KDirector | Buyindirect | 36 | $193.21 | $7k | May 12, 2020 |
| BRAINERD MARY KDirector | Buyindirect | 11 | $221.03 | $2k | Sep 12, 2019 |
| BRAINERD MARY KDirector | Buyindirect | 63 | $202.21 | $13k | Jun 26, 2019 |
No analyst notes on SYK yet.
Analyst Ratings
25 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 7 | 15 | 6 | 0 | 0 | Buy1.96 |
| 1 mo ago | 7 | 16 | 5 | 0 | 0 | Buy1.93 |
| 2 mo ago | 7 | 14 | 6 | 0 | 0 | Buy1.96 |